Patent
The subject of the invention is the genomic sequence and the nucleotide sequences encoding polypeptides of Chlamydia trachomatis , such as cellular envelope polypeptides, which are secreted or specific, or which are involved in metabolism, in the replication process or in virulence, polypeptides encoded by such sequences, as well as vectors including the said sequences and cells or animals transformed with these vectors. The invention also relates to transcriptional gene products of the Chlamydia trachomatis genome, such as, for example, antisense and ribozyme molecules, which can be used to control growth of the microorganism. The invention also relates to methods of detecting these nucleic acids or polypeptides and kits for diagnosing Chlamydia trachomatis infection. The invention also relates to a method of selecting compounds capable of modulating bacterial infection and a method for the biosynthesis or biodegradation of molecules of interest using the said nucleotide sequences or the said polypeptides. The invention finally comprises, pharmaceutical, in particular vaccine, compositions for the prevention and/or treatment of bacterial, in particular Chlamydia trachomatis , infections.
1. An isolated polynucleotide sequence obtained from Chlamydia trachomatis comprising a polynucleotide sequence encoding a polypeptide selected from the group consisting of SEQ ID NO. 1083, SEQ ID NO. 1089, SEQ ID NO. 1091, SEQ ID NO. 1095, SEQ ID NO. 1096, SEQ ID NO. 1105, SEQ ID NO. 1117, SEQ ID NO. 1159, and SEQ ID NO. 1167.
2. A polynucleotide encoding a fusion protein, comprising a polynucleotide according claim 1 ligated in frame to a polynucleotide encoding a heterologous polypeptide.
3. A recombinant vector that contains the polynucleotide of claim 1 .
4. A recombinant vector that contains the polynucleotide of claim 2 .
5. A recombinant vector that contains the polynucleotide of claim 1 , operatively associated with a regulatory sequence that controls gene expression.
6. A recombinant vector that contains the polynucleotide of claim 2 operatively associated with a regulatory sequence that controls gene expression.
7. A genetically engineered host cell that contains the polynucleotide of claim 1 or 3 , or a recombinant vector according to claim 4 or 6 .
8. A genetically engineered host cell that comprises the polynucleotide of claim 2 , or a recombinant vector according to claim 4 or 6 .
9. A genetically engineered host cell that contains the polynucleotide of claim 1 or operatively associated with a regulatory sequence that controls gene expression in the host cell.
10. A genetically engineered host cell that contains the polynucleotide of claim 2 operatively associated with a regulatory sequence that controls gene expression in the host cell.
11. A DNA chip containing an array of polynucleotides comprising at least one of the polynucleotides of claim 1 .
12. A kit comprising a container containing an isolated polynucleotide of claim 1 .
13. The kit of claim 12 wherein the polynucleotide is a primer or a probe.
14. An isolated polynucleotide comprising a polynucleotide that encodes a polypeptide sequence selected from the group consisting of SEQ ID NO. 1083, SEQ ID NO. 1089, SEQ ID NO. 1091, SEQ ID NO. 1095, SEQ ID NO. 1096, SEQ ID NO. 1105, SEQ ID NO. 1117, SEQ ID NO. 1159, or SEQ ID NO. 1167 wherein the polynucleotide that encodes the polypeptide sequence has the polynucleotide sequence of the genomic DNA obtainable from ECACC Deposit No. 981 12618.
15. An isolated polynucleotide sequence comprising, a polynucleotide sequence that encodes a polypeptide sequence selected from the group consisting of SEQ ID NO. 1083, SEQ ID NO. 1089, SEQ ID NO. 1091, SEQ ID NO. 1095, SEQ ID NO. 1096, SEQ ID NO, 1105, SEQ ID NO. 1117, SEQ ID NO. 1159, or SEQ ID NO. 1167, wherein the polynucleotide that encodes the polypeptide sequence has the polynucleotide sequence of the clone DNA obtainable from ECACC Deposit No. 98112617.
16. An isolated polynucleotide sequence comprising:
a) nucleotides 78482 to 78736 of SEQ ID NO: 1 (ORF 1083);
b) (the polynucleotide sequence complementary to the full length of nucleotides 112069 through 111734 of SEQ ID NO: 1 (ORF 1089);
c) nucleotides 144164 to 144427 of SEQ ID NO: 1 (ORF 1095);
d) the polynucleotide sequence complementary to the full length of nucleotides 150698 through 150369 of SEQ ID NO: 1 (ORF 1096);
e) the polynucleotide sequence complementary to the full length of nucleotides 197313 through 197083 of SEQ ID NO: 1 (ORF 1105);
f) nucleotides 303155 to 303469 of SEQ ID NO: 1 (ORF 1117);
g) nucleotides 610110 to 610391 of SEQ ID NO: 1 (ORF 1159); or
h) the polynucleotide sequence complementary to the full length of nucleotides 679528 through 679253 of SEQ ID NO: 1 (ORF 1167).
17. A recombinant vector comprising a polynucleotide according to claim 16 .
18. A genetically engineered host cell comprising a recombinant vector according to claim 17 .
19. A DNA chip comprising a polynucleotide according to claim 16 .
20. A polynucleotide encoding a fusion protein comprising a polynucleotide according to claim 16 ligated in frame to a polynucleotide encoding a heterologous polypeptide.
21. A recombinant polynucleotide comprising a polynucleotide according to claim 16 operatively associated with a regulatory sequence that controls gene expression.
22. A recombinant polynucleotide comprising a polynucleotide according to claim 20 operatively associated with a regulatory sequence that controls gene expression.